Prediction of Cognitive Status and 5-Year Survival Rate for Elderly with Cardiovascular Diseases: A Canadian Study of Health and Aging Secondary Data Analysis

• Published in: The Journal of frailty & aging 2021-01, Vol.10 (1), p.31-37
• Main Authors: Pakzad, S, Bourque, P, Fallah, N
• Format: Article
• Language: English
• Subjects: Activities of daily living; Aged; Aged, 80 and over; Aging; Aging - psychology; Aphasia; Apraxia; Canada - epidemiology; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - mortality; Cardiovascular Diseases - psychology; Change agents; Clinical outcomes; Cognition - physiology; Cognitive ability; Cognitive Aging; Cognitive change; Cognitive functioning; Cognitive impairment; Data Analysis; Dementia; Diabetes; Frail Elderly - psychology; Frailty; Frailty - psychology; Geriatric Assessment - methods; Heart failure; Humans; Hypertension; Longitudinal studies; Measurement; Medical prognosis; Memory; Mortality; Mortality rates; Older people; Risk factors; Survival Rate; Variables
• ISSN: 2260-1341; 2273-4309
• DOI: 10.14283/jfa.2020.21

Given the important association between cardiovascular disease and cognitive decline, and their significant implications on frailty status, the contribution of neurocognitive frailty measure helping with the assessment of patient outcomes is dearly needed. The present study examines the prognostic value of the Neurocognitive Frailty Index (NFI) in the elderly with cardiovascular disease. Secondary analysis of the Canadian Study of Health and Aging (CSHA) dataset was used for prediction of 5-year cognitive changes. Community and institutional sample. Canadians aged 65 and over [Mean age: 80.4 years (SD=6.9; Range of 66-100)]. Neurocognitive Frailty Index (NFI) and Modified Mini-Mental State (3MS) scores for cognitive functioning of all subjects at follow-up and mortality rate were measured. The NFI mean score was 9.63 (SD = 6.04) and ranged from 0 to 33. This study demonstrated that the NFI was significantly associated with cognitive changes for subjects with heart disease and this correlation was a stronger predictor than age. The clinical relevance of this study is that our result supports the prognostic utility of the NFI tool in treatment planning for those with modifiable cardiovascular disease risk factors in the development of dementia.